Difference in sensitivity between SARS-CoV-2–specific T cell assays in patients with underlying conditions
Rory D. de Vries, … , Debbie van Baarle, RECOVAC-IR Collaborators
Rory D. de Vries, … , Debbie van Baarle, RECOVAC-IR Collaborators
Published December 15, 2021
Citation Information: J Clin Invest. 2021;131(24):e155499. https://doi.org/10.1172/JCI155499.
View: Text | PDF
Letter to the Editor Immunology Virology

Difference in sensitivity between SARS-CoV-2–specific T cell assays in patients with underlying conditions

Abstract

Authors

Rory D. de Vries, Marieke van der Heiden, Daryl Geers, Celine Imhof, Debbie van Baarle, RECOVAC-IR Collaborators

×

Full Text PDF | Download (171.76 KB)